爱萨尔生物

Biotech/Healthcare

Shanghai IxCell Biotechnology Co., Ltd.’s founding team comes from U.S. research institutions focused on induced pluripotent stem cells, including the University of Wisconsin–Madison, where iPSC technology originated, as well as U.S.

Latest round: Series A (2022)